JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Issioui, T. Articles by Marple, B. F. Search for Related Content PubMed PubMed Citation Articles by Issioui, T. Articles by Marple, B. F.

---

AMBULATORY ANESTHESIA

The Efficacy of Premedication with Celecoxib and Acetaminophen in Preventing Pain After Otolaryngologic Surgery

Tijani Issioui, MD^*, Kevin W. Klein, MD^*, Paul F. White, PhD MD, FANZCA^*, Mehernoor F. Watcha, MD, Margarita Coloma, MD^*, Gary D. Skrivanek, MD^*, Stephanie B. Jones, MD^*, Kevin C. Thornton, BS^*, and Bradley F. Marple, MD

Departments of *Anesthesiology and Pain Management and Otolaryngology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas; and Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Address correspondence to Dr. P. F. White, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9068. Address e-mail to paul.white{at}utsouthwestern.edu

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Non-opioid analgesics are often used to supplement opioids for the management of perioperative pain. In this randomized, double-blinded, placebo-controlled study, we examined the effects of acetaminophen and a cyclooxygenase type-2 inhibitor, celecoxib, when administered alone or in combination, before elective otolaryngologic surgery in 112 healthy outpatients. Subjects were assigned to 1 of 4 study groups: Group 1, placebo (vitamin C, 500 mg per os [PO]); Group 2, acetaminophen 2000 mg PO; Group 3, celecoxib 200 mg PO; or Group 4, acetaminophen 2000 mg and celecoxib 200 mg PO. All patients received a standardized anesthetic technique. During the postoperative period, pain was assessed using a 10-point verbal rating scale. Recovery times, the need for rescue analgesics, side effects, and patient satisfaction scores were also recorded. The combination of acetaminophen and celecoxib was significantly more effective than placebo in reducing postoperative pain. Celecoxib, when administered alone or in combination with acetaminophen, improved patients’ satisfaction with their postoperative analgesia. With the combination of acetaminophen and celecoxib, an additional expenditure of $6.16 would be required to obtain complete satisfaction with postoperative pain management in one additional patient who would not have been completely satisfied if he/she had received the placebo. However, oral celecoxib or acetaminophen alone was not significantly more effective than placebo in reducing postoperative pain when administered before surgery. We conclude that oral premedication with a combination of acetaminophen (2000 mg) and celecoxib (200 mg) was highly effective in decreasing pain and improving patient satisfaction after outpatient surgery.

IMPLICATIONS: Oral premedication with a combination of acetaminophen (2000 mg) and celecoxib (200 mg) was effective in decreasing pain and improving patient satisfaction after otolaryngologic surgery. However, acetaminophen (2000 mg) or celecoxib (200 mg) alone was not significantly more effective than placebo in reducing postoperative pain.

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Interest in finding alternatives to opioid analgesics for the treatment and prevention of postoperative pain in the ambulatory setting has led to an increasing use of nonsteroidal antiinflammatory drugs (NSAIDs). However, classical NSAIDs block the synthesis of prostaglandins by inhibiting both cyclooxygenase type-1 (COX-1) and cyclooxygenase type-2 (COX-2), and may produce operative site and gastrointestinal bleeding, as well as renal tubular dysfunction. The COX-2-specific drugs have been recently introduced as alternatives to the classical NSAIDs, allegedly producing comparable analgesia without NSAIDs-like side effects (1,2).

Previous studies have reported that NSAIDs (e.g., ibuprofen, ketorolac) are useful in decreasing pain and/or opioid usage after oral, dental, and gynecologic surgical procedures in the outpatient setting (3–8). Acetaminophen, another non-opioid analgesic, is also effective when administered rectally before pediatric ambulatory surgery procedures in dosages exceeding 30 mg/kg (9–12).

Therefore, we designed a randomized, double-blinded, placebo-controlled study to evaluate the analgesic efficacy of celecoxib and acetaminophen when administered alone or in combination before ambulatory surgery. Our hypothesis was that oral premedication with celecoxib alone or in combination with acetaminophen would improve patient satisfaction by reducing pain after otolaryngologic (ears, nose, throat [ENT]) surgical procedures, which are usually performed on an ambulatory basis. A secondary objective was to determine the cost of using celecoxib and/or acetaminophen to improve patients’ satisfaction with their postoperative pain management.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
After obtaining IRB approval and written informed consent, 112 healthy outpatients (aged 18 to 75 yr) undergoing ENT procedures were studied according to a randomized, double-blinded, placebo-controlled protocol. Patients were excluded if they had received any analgesic medication within 12 h before surgery, were pregnant, breast-feeding, were allergic to any of the medications used in the study, had a history of drug abuse, or clinically significant cardiovascular, renal, hepatic, or gastrointestinal disease.

In the preoperative holding area, patients completed verbal rating scales (VRS) for pain and nausea, with 0 = none to 10 = worst imaginable. Patients were randomly assigned to 1 of 4 treatment groups: Group 1, placebo (vitamin C, 500 mg PO); Group 2, acetaminophen 2000 mg PO; Group 3, celecoxib 200 mg PO; and Group 4, acetaminophen 2000 mg and celecoxib 200 mg PO. The doses of study medication were based on previously published data (2,5,12). These drugs were prepared by the operating room pharmacist according to a computer-generated random number schedule, and administered with 15 mL of water 30–60 min before the induction of anesthesia. Patients, observers, and those involved in the postoperative patient care were blinded to the content of the oral premedication.

Patients were also premedicated with midazolam 20 µg/kg IV. Anesthesia was induced with propofol 1.5–2 mg/kg IV, and remifentanil 0.5 µg/kg IV, and tracheal intubation was facilitated with rocuronium 0.6 mg/kg IV. Anesthesia was maintained with desflurane 4%–6% end-tidal concentration in combination with air (0.5 L/min) and oxygen (0.5 L/min). An infusion of remifentanil was administered at an initial rate of 0.125 µg · kg^-1 · min^-1 IV and subsequently titrated from 0.0625 to 0.25 µg · kg^-1 · min^-1 IV to maintain heart rate and blood pressure within 15% of the baseline values. At the end of the surgical procedure, residual neuromuscular block was antagonized with edrophonium 50–80 µg/kg IV, and atropine 0.5–0.8 mg IV, and the maintenance anesthetic drugs were discontinued.

Recovery times to awakening (e.g., spontaneous eye opening in response to a verbal command) and orientation to person, date, and place were determined by a blinded observer (TI) at 1-min intervals after discontinuation of the maintenance anesthetics. Patients rated their pain and nausea scores on a 10-point VRS at 30-min intervals and just before receiving any rescue drug in the postanesthesia care unit (PACU). Patients with pain VRS scores of six or higher were considered to have severe pain. Patients complaining of moderate-to-severe pain (VRS > 3) were treated with fentanyl 25 µg IV at 5–10-min intervals until adequate pain relief was achieved. Patients with pain VRS scores of 2–3 received a combination of oral hydrocodone (5 mg) and acetaminophen (500 mg). Nausea and episodes of vomiting were managed with dolasetron 12.5 mg IV, and if the emetic symptoms persisted, promethazine 6.25 mg IV was administered to a total dose of 25 mg.

Postoperative side effects (e.g., pain, nausea, vomiting) and the requirements for "rescue" analgesic and antiemetic drugs were recorded, as well as the durations of stay in the PACU (Phase I) and step-down (Phase II) recovery unit, and the time to be considered fit for discharge ("home ready"). The criteria used to determine fitness for discharge required that the patient be awake, alert, with stable vital signs on standing, experiencing no intractable postoperative side effects, and be able to walk without assistance.

Follow-up evaluations were performed via a telephone interview at 24 h after surgery to determine the number of doses of oral opioid-containing analgesic medications consumed, along with the patient’s evaluation of his or her maximal pain after discharge using the 10-point VRS. Patients’ satisfaction with their postoperative pain management and the quality of their recovery score were assessed by using a 100-point VRS, with 0 = poor to 100 = excellent. Patients who rated their satisfaction with pain management as excellent (VRS = 100) were considered to have complete satisfaction with postoperative pain control. The incidence of complete satisfaction with pain management was calculated separately for each of the study groups, and then subtracted from the incidence of complete satisfaction in the Placebo group to obtain the absolute difference in this outcome variable. The number-needed-to-treat (NNT) was calculated as the reciprocal of the absolute difference between the study and placebo groups in the incidence of complete satisfaction with their pain management.

The cost analysis was an incremental cost analysis performed from the perspective of a chief financial officer, and costs that were common to all four groups were not considered in the analysis. However, the acquisition costs of oral drugs administered in the preoperative phase were used in the cost analysis. The product of the NNT and the costs of the oral premedication drugs provided the additional expenditure required to obtain complete satisfaction with pain management in one patient who would not have been completely satisfied if treated with the placebo.

This study was designed to assess the ability of drugs given before the induction of anesthesia to reduce postoperative pain. Therefore, the standard end-points of pain intensity difference, pain relief over time, and time to onset of pain relief were not used. The analgesic efficacy of the study drugs was assessed by comparing the maximal pain scores before rescue in the postoperative period, the time-related proportion of patients requiring rescue, and the dose of rescue analgesic medications required in each treatment group.

The primary end-point of this study was the percentage of patients with moderate-to-severe postoperative pain. An a priori power analysis estimated that 28 patients would be required in each group. This was based on the following assumptions: 1) the incidence of moderate-to-severe pain in the Placebo group would be similar to that in a previously published study in this patient population in which a similar anesthetic regimen was used (13), 2) a 35% absolute reduction (from 70% to 35%) in the incidence of moderate-to-severe pain was considered of clinical importance, 3) a type I error of 0.05 not adjusted for multiple comparisons, and 4) power = 80%.

Data analysis was performed by using Statview^® for Windows^® version 5.0.1 (SAS Institute, Cary, NC). Normally distributed continuous data were analyzed by using one-way analysis of variance and if significant differences were noted, a Student-Newman-Keuls test was used for intergroup comparisons. Postoperative pain scores were analyzed by a repeated measures analysis of variance. Data not normally distributed were analyzed by using a Kruskal-Wallis nonparametric analysis of variance, and if significant differences were present, intergroup comparisons were performed with a Mann-Whitney U-test. Categorical data were analyzed by using the ² test with Yates’ continuity correction or Fisher’s exact test where appropriate. Data were presented as mean values ± SD, median values (interquartile range), numbers, or percentages. A P value < 0.05 was considered statistically significant.

	Results

Top Abstract Introduction Methods Results Discussion References

 
There were no significant differences among the four treatment groups with respect to age, weight, sex, type and duration of surgery and anesthesia, and intraoperative opioid analgesic medication (Table 1). Baseline pain and nausea scores were also similar in all four groups. There were no significant differences in the times from discontinuation of maintenance anesthetics to eye opening, response to commands, or orientation (Table 2). In addition, there were no differences in the time spent in the Phase I and II recovery units, or in the times to achieve home readiness ("fit for discharge").

The maximal pain scores and the number of doses of oral analgesic medication taken after discharge were significantly higher in the Placebo group compared with the Combination group (Table 3). More important, patients in the Combination group were more highly satisfied with their postoperative pain management (96 ± 5) than the Placebo group (82 ± 12). The percentage of patients who were completely satisfied with their postoperative pain management was also significantly larger in the Combination and Celecoxib groups compared with the Placebo group (61% in the Combination group compared with 46%, 32%, and 11% for the Celecoxib, Acetaminophen, and Placebo groups, respectively) (Table 3). The NNT for complete satisfaction with postoperative analgesia in the Celecoxib alone and in the Combination group were 3 (95% confidence limits 2.0–11.5) and 2 (95% confidence limits 1.4–4.1), respectively. The postdischarge nausea scores were significantly larger in the Placebo group compared with the Celecoxib and Combination groups (1.9 ± 2.3 for the Placebo group versus 0.4 ± 1.2 and 0.2 ± 0.9 for the Celecoxib and Combination groups, respectively). Finally, the overall quality of recovery was significantly improved in the Combination group compared with the Placebo group (90 ± 17 versus 81 ± 13) (Table 3).

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
Achieving effective pain control after outpatient surgery continues to be a clinically significant issue in facilitating the recovery process and enhancing patient satisfaction after ambulatory surgery (14). Although opioids remain the most effective analgesics, their associated side effects (e.g., nausea, vomiting, drowsiness, and respiratory depression) can delay discharge after ambulatory surgery. NSAIDs are effective in reducing postoperative pain after dental and other minor surgical procedures. However, there is a "ceiling effect" with respect to the analgesia produced by NSAIDs and, therefore, they are optimally used as adjuvants to reduce postoperative opioid requirements (1,15–17).

In this study, the preoperative oral administration of a combination of acetaminophen (2000 mg) and celecoxib (200 mg) was effective in reducing pain in the postoperative period and the need for opioid-containing oral analgesic medication after discharge, as well as in improving patient satisfaction after surgery. However, we did not find that these doses of celecoxib or acetaminophen when administered alone were significantly more effective than placebo in reducing pain in this adult population undergoing ambulatory surgery. It is possible that a larger study size or use of larger doses of acetaminophen (3–4 g) and celecoxib (400 mg) would have shown statistically significant differences in postoperative pain scores among the Acetaminophen, Celecoxib, and Placebo groups, and may have also shown differences in other analgesic end-points (e.g., the dose of rescue analgesics and the time to first rescue).

A placebo-controlled study in children undergoing ambulatory surgery procedures confirmed the dose-dependent efficacy of acetaminophen as an analgesic in the postoperative period (12). In a pediatric ENT study, Rusy et al. (18) reported that rectal acetaminophen (35 mg/kg) was as effective as ketorolac (1 mg/kg IV) for postoperative pain control. More recent pharmacokinetic studies suggest that acetaminophen blood levels of 10 mg/mL are required for satisfactory analgesia (10,11). The bioavailability of rectally administered acetaminophen is allegedly less than with oral dosing because the absorption of acetaminophen from suppositories is less predictable (9,19).

Similar pharmacokinetic data on analgesic blood levels of oral acetaminophen in adults are not available, and there are conflicting data on the analgesic efficacy of rectal acetaminophen in adults. Cobby et al. (20) noted that rectal acetaminophen (1300 mg) had a morphine-sparing effect after hysterectomy. However, Hein et al. (19) failed to demonstrate analgesia with rectal doses of 1000 mg after minor gynecologic surgery. In contrast to these data on the rectal route, there is good evidence that oral acetaminophen, 650–1000 mg, has a significant analgesic effect after dental and oral surgery, and in women who had undergone episiotomy procedures (4,5,15,21–23). We used a larger oral dose of acetaminophen (2000 mg) in our ENT study and yet, failed to demonstrate a statistically significant analgesic effect. However, in this adult surgical population, the acetaminophen dose was equivalent to "only" 25 mg/kg.

Combinations of NSAIDs with acetaminophen should be more effective than either drug alone, because they possess different sites of analgesic action. It may therefore be possible to provide effective analgesia with smaller doses of acetaminophen and celecoxib than were used in this study if they are administered in combination for oral premedication. Analogous to our findings, combinations of diclofenac and acetaminophen were effective in reducing pain after both gynecologic and oral surgical procedures (16,24). It is a common clinical practice to use fixed dosage combinations of acetaminophen with oral opioids such as codeine, hydrocodone, or oxycodone for pain management after discharge (6,7,25,26).

The classical NSAIDs (e.g., ketorolac, diclofenac, naproxen) are nonselective at the COX-1 and COX-2 receptor sites. As a result, these drugs can produce adverse effects on gastric mucosal function and hemostasis, and are contraindicated in the presence of peptic ulcers and for procedures with an "open" surgical site (e.g., tonsillectomy) (2,17,18). The newer COX-2 inhibitors (e.g., celecoxib, rofecoxib) are more selective and should have a decreased potential for these adverse effects. Although celecoxib is usually used for treating rheumatoid and osteoarthritis, it has recently been recommended for the treatment of acute pain (27). In a comparative study involving celecoxib and rofecoxib, Reuben and Connelly (17) reported that celecoxib produced a shorter-lasting analgesic effect than rofecoxib after spinal fusion surgery. In our study, celecoxib (200 mg PO) did not offer any significant advantage over acetaminophen 2000 mg in the prevention of postoperative pain. The time to maximal plasma concentration of celecoxib is 2–4 hours after oral ingestion (2), and our patients received the study drugs 30–60 min before the induction of anesthesia and 120–180 min before arrival in the PACU. Therefore, this should have been an adequate time interval for therapeutic blood levels to be achieved.

Newer drugs (e.g., celecoxib) may be more expensive than the currently available generic oral analgesics. However, patients receiving celecoxib alone or in combination with acetaminophen were more satisfied with their postoperative pain management and quality of recovery than the Placebo (control) group. In fact, our study suggests that the NNT for increased patient satisfaction with the combination regimen was only two. Therefore, it would require an additional expenditure of $6.16 to obtain complete satisfaction with the postoperative pain management in one additional patient who would not have been satisfied if he/she had received the placebo treatment. By comparison, the costs to improve patient satisfaction in one additional patient when ondansetron is administered prophylactically exceeds $400 (28).

This study can be criticized for the type of surgical procedures chosen for this analgesic study. Although ENT surgery might not be considered an operation that is associated with a frequent incidence of severe postoperative pain, we found that 50% of the patients in the Placebo group experienced moderate-to-severe pain in the early postoperative period. Furthermore, previous studies have demonstrated that pain after ENT surgery is an acceptable model for studying non-opioid analgesics (18).

We conclude that oral premedication with a combination of celecoxib (200 mg) and acetaminophen (2000 mg) was highly effective in decreasing postoperative pain and improving patient satisfaction after ambulatory ENT surgery. Patients’ satisfaction with their postoperative pain management was also improved with celecoxib alone; however, the NNT to achieve this improvement was larger than with the celecoxib-acetaminophen combination. In this outpatient surgery population, celecoxib (200 mg) and acetaminophen (2 g) alone were not significantly more effective than a placebo in reducing postoperative pain when administered orally before surgery.

	Acknowledgments

 
Finanacial support was provided by the White Mountain Institute in Los Altos, CA (this is a non-for-profit private foundation and PFW is the President).

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand 2000; 44: 1191–203.[ISI][Medline]
2. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 433–42.[Free Full Text]
3. Forbes JA, Butterworth GA, Burchfield WH, Beaver WT. Evaluation of ketorolac, aspirin, and an acetaminophen-codeine combination in postoperative oral surgery pain. Pharmacotherapy 1990; 10: 77S-93S.[Medline]
4. McQuay HJ, Carroll D, Guest P, et al. A multiple dose comparison of combinations of ibuprofen and codeine and paracetamol, codeine and caffeine after third molar surgery. Anaesthesia 1992; 47: 672–7.[ISI][Medline]
5. Mehlisch DR, Sollecito WA, Helfrick JF, et al. Multicenter clinical trial of ibuprofen and acetaminophen in the treatment of postoperative dental pain. J Am Dental Assoc 1990; 121: 257–63.[Abstract]
6. Palangio M, Wideman GL, Keffer M, et al. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain. Clin Ther 2000; 22: 600–12.[ISI][Medline]
7. Raeder JC, Steine S, Vatsgar TT. Oral ibuprofen versus paracetamol plus codeine for analgesia after ambulatory surgery. Anesth Analg 2001; 92: 1470–2.[Free Full Text]
8. Turek MD, Baird WM. Double-blind parallel comparison of ketoprofen (Orudis), acetaminophen plus codeine, and placebo in postoperative pain. J Clin Pharmacol 1988; 28: S23–8.[Abstract]
9. Anderson BJ, Holford NH, Woollard GA, et al. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology 1999; 90: 411–21.[ISI][Medline]
10. Birmingham PK, Tobin MJ, Henthorn TK, et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology 1997; 87: 244–52.[ISI][Medline]
11. Birmingham PK, Tobin MJ, Fisher DM, et al. Initial and subsequent dosing of rectal acetaminophen in children: a 24-hour pharmacokinetic study of new dose recommendations. Anesthesiology 2001; 94: 385–9.[ISI][Medline]
12. Korpela R, Korvenoja P, Meretoja OA. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology 1999; 91: 442–7.[ISI][Medline]
13. Zarate E, Watcha MF, White PF, et al. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis. Anesth Analg 2000; 90: 1352–8.[Abstract/Free Full Text]
14. Chung F, Mezei G. Factors contributing to a prolonged stay after ambulatory surgery. Anesth Analg 1999; 89: 1352–9.[Abstract/Free Full Text]
15. Forbes JA, Kehm CJ, Grodin CD, Beaver WT. Evaluation of ketorolac, ibuprofen, acetaminophen, and an acetaminophen-codeine combination in postoperative oral surgery pain. Pharmacotherapy 1990; 10: 94S-5S.[Medline]
16. Montgomery JE, Sutherland CJ, Kestin IG, Sneyd JR. Morphine consumption in patients receiving rectal paracetamol and diclofenac alone and in combination. Br J Anaesth 1996; 77: 445–7.[Abstract/Free Full Text]
17. Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000; 91: 1221–5.[Abstract/Free Full Text]
18. Rusy LM, Houck CS, Sullivan LJ, et al. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995; 80: 226–9.[Abstract]
19. Hein A, Jakobsson J, Ryberg G. Paracetamol 1 g given rectally at the end of minor gynaecological surgery is not efficacious in reducing postoperative pain. Acta Anaesthesiol Scand 1999; 43: 248–51.[ISI][Medline]
20. Cobby TF, Crighton IM, Kyriakides K, Hobbs GJ. Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br J Anaesth 1999; 83: 253–6.[Abstract/Free Full Text]
21. Kiersch TA, Halladay SC, Hormel PC. A single-dose, double-blind comparison of naproxen sodium, acetaminophen, and placebo in postoperative dental pain. Clin Ther 1994; 16: 394–404.[ISI][Medline]
22. Schachtel BP, Thoden WR, Baybutt RI. Ibuprofen and acetaminophen in the relief of postpartum episiotomy pain. J Clin Pharmacol 1989; 29: 550–3.[Abstract]
23. Sunshine A, Olson NZ, Zighelboim I, De Castro A. Ketoprofen, acetaminophen plus oxycodone, and acetaminophen in the relief of postoperative pain. Clin Pharmacol Ther 1993; 54: 546–55.[ISI][Medline]
24. Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Ther 1999; 66: 625–35.[ISI][Medline]
25. Rawal N, Allvin R, Amilon A, et al. Postoperative analgesia at home after ambulatory hand surgery: a controlled comparison of tramadol, metamizol, and paracetamol. Anesth Analg 2001; 92: 347–51.[Abstract/Free Full Text]
26. Vangen O, Doessland S, Lindbaek E. Comparative study of ketorolac and paracetamol/codeine in alleviating pain following gynaecological surgery. J Int Med Res 1988; 16: 443–51.[ISI][Medline]
27. Clemett D, Goa KL. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis, and acute pain. Drugs 2000; 59: 957–80.[ISI][Medline]
28. Scuderi PE, James RL, Harris L, Mims GR III. Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment. Anesthesiology 1999; 90: 360–71.[ISI][Medline]

This article has been cited by other articles:

				S. S. Reuben, E. F. Ekman, and D. Charron Evaluating the Analgesic Efficacy of Administering Celecoxib as a Component of Multimodal Analgesia for Outpatient Anterior Cruciate Ligament Reconstruction Surgery Anesth. Analg., July 1, 2007; 105(1): 222 - 227. [Abstract] [Full Text] [PDF]

				P. F. White, H. Kehlet, J. M. Neal, T. Schricker, D. B. Carr, F. Carli, and the Fast-Track Surgery Study Group The Role of the Anesthesiologist in Fast-Track Surgery: From Multimodal Analgesia to Perioperative Medical Care Anesth. Analg., June 1, 2007; 104(6): 1380 - 1396. [Abstract] [Full Text] [PDF]

				P. F. White, O. Sacan, B. Tufanogullari, M. Eng, N. Nuangchamnong, and B. Ogunnaike Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery: [Effet de l'administration postoperatoire a court terme de celecoxib sur l'evolution des patients apres une chirurgie par laparoscopie sans hospitalisation] Can J Anesth, May 1, 2007; 54(5): 342 - 348. [Abstract] [Full Text] [PDF]

				E. Munsterhjelm, T. T. Niemi, O. Ylikorkala, P. J. Neuvonen, and P. H. Rosenberg Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers Br. J. Anaesth., August 1, 2006; 97(2): 226 - 231. [Abstract] [Full Text] [PDF]

				A. Turan, P. F. White, B. Karamanlioglu, D. Memis, M. Tasdogan, Z. Pamukcu, and E. Yavuz Gabapentin: An Alternative to the Cyclooxygenase-2 Inhibitors for Perioperative Pain Management Anesth. Analg., January 1, 2006; 102(1): 175 - 181. [Abstract] [Full Text] [PDF]

				P. F. White The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain Anesth. Analg., November 1, 2005; 101(5S_Suppl): S5 - 22. [Abstract] [Full Text] [PDF]

				P. F. White Update on ambulatory anesthesia Can J Anesth, June 1, 2005; 52(suppl_1): R10 - R10. [Full Text] [PDF]

				S. S. Reuben and E. F. Ekman The Effect of Cyclooxygenase-2 Inhibition on Analgesia and Spinal Fusion J. Bone Joint Surg. Am., March 1, 2005; 87(3): 536 - 542. [Abstract] [Full Text] [PDF]

				R. M. Pertusi Selective Cyclooxygenase Inhibition in Pain Management J Am Osteopath Assoc, November 1, 2004; 104(11_suppl): 19S - 24S. [Abstract] [Full Text] [PDF]

				H. Ma, J. Tang, P. F. White, A. Zaentz, R. H. Wender, A. Sloninsky, R. Naruse, R. Kariger, R. Quon, D. Wood, et al. Perioperative Rofecoxib Improves Early Recovery After Outpatient Herniorrhaphy Anesth. Analg., April 1, 2004; 98(4): 970 - 975. [Abstract] [Full Text] [PDF]

				W. Joshi, N. R. Connelly, S. S. Reuben, M. Wolckenhaar, and N. Thakkar An Evaluation of the Safety and Efficacy of Administering Rofecoxib for Postoperative Pain Management Anesth. Analg., July 1, 2003; 97(1): 35 - 38. [Abstract] [Full Text] [PDF]

				M. F. Watcha, T. Issioui, K. W. Klein, and P. F. White Costs and Effectiveness of Rofecoxib, Celecoxib, and Acetaminophen for Preventing Pain After Ambulatory Otolaryngologic Surgery Anesth. Analg., April 1, 2003; 96(4): 987 - 994. [Abstract] [Full Text] [PDF]

				A. Turan, S. Emet, B. Karamanlioglu, D. Memis, N. Turan, and Z. Pamukcu Analgesic Effects of Rofecoxib in Ear-Nose-Throat Surgery Anesth. Analg., November 1, 2002; 95(5): 1308 - 1311. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Issioui, T. Articles by Marple, B. F. Search for Related Content PubMed PubMed Citation Articles by Issioui, T. Articles by Marple, B. F.

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999